Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Benralizumab
(Fasenra (TN))		1件: Benralizumab (Fasenra)1件: Benralizumab (Fasenra (TN)) 💬1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299 💬
2Biological: Benralizumab, Biological: Placebo to Mepolizumab
(Fasenra (TN))		2件: Benralizumab (Fasenra),
Mepolizumab		2件: Mepolizumab ,
Benralizumab (Fasenra (TN)) 💬		2件: IL5,
IL5RA 💬		13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 44 💬
3Biological: Mepolizumab, Biological: Placebo to Benralizumab
(Fasenra (TN))		2件: Benralizumab (Fasenra),
Mepolizumab		2件: Mepolizumab ,
Benralizumab (Fasenra (TN)) 💬		2件: IL5,
IL5RA 💬		13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 44 💬
4Fasenra1件: Benralizumab (Fasenra)1件: Benralizumab (Fasenra (TN)) 💬1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299 💬